BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

  July 9, 2025

   · 

  6 min read
• Press Releases

  Aptar’s Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices

  July 9, 2025

   · 

  4 min read
• Press Releases

  BioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology

  July 9, 2025

   · 

  5 min read
• Press Releases

  Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025

  July 9, 2025

   · 

  5 min read
• Press Releases

  Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM43 Platform for Breast Surgery

  July 9, 2025

   · 

  5 min read
• Press Releases

  Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study

  July 9, 2025

   · 

  3 min read
• Press Releases

  GenSight Biologics Reports Cash Position as of June 30, 2025

  July 9, 2025

   · 

  5 min read
• Press Releases

  Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolio

  July 9, 2025

   · 

  7 min read
• Press Releases

  Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

  July 9, 2025

   · 

  6 min read
• Press Releases

  RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance

  July 9, 2025

   · 

  6 min read